Appendix D

Committee Member and Staff Biosketches

Sheila P. Burke, M.P.A., R.N., FAAN (Cochair), is an adjunct lecturer at the J. F. Kennedy School of Government at Harvard University, where she previously served as executive dean. She is also the senior public policy advisor and chair of the Government Relations and Policy Group at Baker Donelson. Ms. Burke is the vice chair of the Commonwealth Fund board of directors and a member of the board of directors of Abt Associates and Ascension Health Care. She was chief of staff to Senate Majority Leader Bob Dole and served as deputy staff director of the Senate Committee on Finance and the Secretary of the Senate, the chief administrative officer of the body. She was a commissioner on the Medicare Payment Advisory Commission and chair of the Kaiser Foundation Board. Early in her career, she was a staff nurse in California. Ms. Burke is a member of the National Academy of Medicine, where she previously served as a member of its council and received the David Rall Award. She is also a fellow of the American Academy of Nursing and member of the National Academy of Public Administration. Ms. Burke graduated from the University of San Francisco and Harvard University and has honorary degrees from Marymount University and the Uniformed Services University of the Health Sciences. She has served on several National Academies committees, most recently as cochair of the Committee on the Review of Federal Policies That Contribute to Racial and Ethnic Health Inequities.

Alina Salganicoff, Ph.D. (Cochair), is a senior vice president and the director of Women’s Health Policy at KFF, where her work focuses on health

policies of importance to women throughout their life-span with an emphasis on coverage and access challenges facing underserved and marginalized women. Dr. Salganicoff has written and lectured extensively on the financing of and access to health services for women on topics ranging from sexual and reproductive health to long-term care. She has served on numerous federal, state, and nonprofit advisory committees. She is also on the advisory panel of the American College of Obstetricians and Gynecologists’ Women’s Preventive Services Initiative and Public Policy Advisory Group of Power to Decide and an associate editor of the peer-reviewed journal Women’s Health Issues. Born in Argentina, she is a native Spanish speaker. She holds a B.S. from Pennsylvania State University and a Ph.D. in health policy from Johns Hopkins Bloomberg School of Public Health. Dr. Salganicoff is a member of the National Academies of Sciences, Engineering, and Medicine (National Academies) Standing Committee on Reproductive Health Equity and Society. She served on the Institute of Medicine committee that issued recommendations for preventive services for women now covered under the Affordable Care Act and National Academies committees on abortion safety and quality, the control and prevention of sexually transmitted infections, and women’s health research.

Neelum T. Aggarwal, M.D., FAMWA, is a professor in the Department of Neurological Sciences at the National Institute on Aging–funded Rush Alzheimer’s Disease Center (Rush University Medical Center) and the center’s senior cognitive neurologist. She is also research director for the Rush Heart Center for Women and steering committee member for the Alzheimer’s Clinical Trial Consortium. Her recent clinical and research interests lie in the diagnosis and clinical management of cognitive change and dementia prevention by identifying how risk factors for cardiovascular disease and stroke—including genetics and blood and neuroimaging biomarkers—vary by race/ethnicity and sex and gender. She has served in numerous leadership roles throughout her career. She is the chief diversity and inclusion officer for the American Medical Women’s Association (AMWA), AMWA Delegate to the American Medical Association (AMA), past chair of the AMA—Women’s Physician Section, and recipient of the 2022 Rush Excellence in Research Award and the 2016 AMWA Women in Science Award. She has also served as the cochair for the Alzheimer’s Association—International Society to Advance Alzheimer’s Research and Treatment Sex Differences and Diversity special interest group and was a member of the Society of Women’s Health Research Alzheimer’s Disease Interdisciplinary Network. Dr. Aggarwal completed her M.D. at Chicago Medical School, residency in neurology at Henry Ford Hospital, and aging and neurodegenerative disorders fellowship at the Rush Alzheimer’s Disease Center.

Veronica Barcelona, Ph.D., M.S.N., P.H.N.A.-B.C., R.N., is a public health nurse, perinatal epidemiologist, and assistant professor at Columbia University School of Nursing. Her research centers on how racism and discrimination underlie mechanisms and risk factors for adverse pregnancy and birth outcomes; the goal is to achieve healthy and safe birth outcomes for all. Her research is funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Betty Irene Moore Nurse Leader Fellowship, and Data Science Institute at Columbia University. She has been recognized for excellence in research by the Friends of the National Institute of Nursing Research Protégé Award, Johns Hopkins University School of Nursing Dean’s Award, International Society for Nurses in Genetics Founders Award, and Connecticut Nurses Association Virginia Henderson award. Dr. Barcelona earned degrees from the University of Michigan (B.S.N.), Johns Hopkins University (M.S.N./M.P.H.), and Tulane University School of Public Health and Tropical Medicine (Ph.D.). She completed postdoctoral studies in epigenomics and a K01 project funded by the National Institute of Nursing Research at Yale University School of Nursing.

Alyssa M. Bilinski, Ph.D., M.Sc., A.M., is the Peterson Family Assistant Professor of Health Policy at Brown University School of Public Health in the Departments of Health Services, Policy, & Practice and Biostatistics. Her research lies at the intersection of policy evaluation and modeling: developing novel methods to support decision making and applying these to identify interventions that can most efficiently improve population health and well-being. She has published extensively in peer-reviewed medical, science, policy, and methods journals, including Journal of the American Medical Association, Annals of Internal Medicine, Proceedings of the National Academy of Sciences, Health Affairs, Journal of Econometrics, and Value in Health, and collaborated with state, local, and federal public health officials to help translate her research into practice. Her current work related to women’s health quantifies the population health effects of excluding pregnant people from clinical trials and defines priorities for addressing gaps in clinical evidence. Dr. Bilinski received a Ph.D. in health policy (evaluative science and statistics) and an A.M. in statistics from Harvard University, an M.Sc. in medical statistics from the London School of Hygiene and Tropical Medicine as a Marshall Scholar, and a B.A. from Yale College.

Chloe E. Bird, Ph.D., M.A., is the director of the Center for Health Equity Research at Tufts Medical Center, Sara Murray Jordan Professor of Medicine at Tufts University School of Medicine, a senior sociologist at RAND, and professor of policy analysis at Pardee RAND Graduate School. She is

a medical sociologist and national expert in women’s health and health disparities, determinants of sex and gender differences in health and health care, gaps in the evidence base on women’s health, and the social and economic impact of increasing investments in research on women’s health. Dr. Bird has served as a senior advisor in the National Institutes of Health Office of Research on Women’s Health and editor of the journal Women’s Health Issues. She received the 2021 Distinguished Career Award in the Practice of Sociology from the American Sociological Association. She is a fellow of the American Association for the Advancement of Science and the American Academy of Health Behavior and a member of Women of Impact in Healthcare. She earned her Ph.D. and M.A. in sociology from the University of Illinois at Urbana-Champaign and her B.A. from Oberlin College.

Susan Cheng, M.D., M.M.Sc., M.P.H., is the Erika J. Glazer Chair in Women’s Cardiovascular Health and Population Science, director of the Institute for Research on Healthy Aging, director of public health research, and professor and vice chair of research in cardiology in the Smidt Heart Institute at Cedars-Sinai. She is a clinician-scientist who leads research programs aimed at uncovering the drivers of cardiovascular aging in women and men. Dr. Cheng consults with companies on off-target cardiac effects of medications. She has authored over 400 research manuscripts, and her work has been supported by continuous National Institutes of Health funding. Dr. Cheng has served on the editorial boards of major cardiovascular journals and leadership committees for the American Heart Association and American College of Cardiology. She is an elected member of the Association of University Cardiologists and elected councilor for the American Society for Clinical Investigation. Dr. Cheng received her A.B. from Harvard University, M.D. from McMaster University, M.M.Sc. from Massachusetts Institute of Technology, and M.P.H. from Harvard School of Public Health. She completed internal medicine training at Johns Hopkins Hospital and cardiology fellowship training at Brigham and Women’s Hospital.

Felina Cordova-Marks, Dr.P.H., M.P.H., M.Sc. (Hopi), is an assistant professor at the University of Arizona Zuckerman College of Public Health in the department of Health Promotion Sciences, executive committee member of the Hopi Education Endowment Fund Board, and associate editor for the American Association for Cancer Research’s journal Cancer Research Communications. She is a published author on topics such as cancer, cardiology, informal health caregiving, mental health, health disparities, and American Indian health. She provides ad hoc consulting on appropriate mechanisms for tribal consultation and culturally responsive training with Indigenous populations. Dr. Cordova-Marks has recently been named a “Health Hero” by the National Indian Health Board, receiving the Regional/Local impact

award for her wellness program IndigiWellbeing^©. She was also named a Diversity and Inclusion Leader for Arizona and is an American Psychosocial Oncology Society Health Equity Scholar. Her awards and recognition include being named Tucson’s Woman of the Year—40 Under 40 by the Tucson Hispanic Chamber of Commerce, Ben’s Bells Honoree, an National Institutes of Health Health Disparities Research Institute Fellow, a Tribal Researchers Cancer Control Fellow, National Native American 40 Under 40, and University of Arizona Centennial Award recipient. Dr. Cordova-Marks earned her M.P.H., M.Sc., and Dr.P.H. from the University of Arizona.

Sherita H. Golden, M.D., M.H.S., is the Hugh P. McCormick Family Professor of Endocrinology and Metabolism at Johns Hopkins University School of Medicine. An internationally recognized physician-scientist, she has used epidemiology and health services research to identify biological and systems contributors to disparities in Type 2 diabetes and its outcomes. She served as vice president and chief diversity officer for Johns Hopkins Medicine (JHM) 2019–2024; she oversaw diversity, inclusion, and health equity strategy and operations for the School of Medicine and Johns Hopkins Health System. She executed implementation of Culturally and Linguistically Appropriate Services Standards; staff training for accurate collection of self-identified patient demographic data; system-wide policies prohibiting patient discrimination and discriminatory aggression toward employees and trainees and allowing for chosen names on identification badges; system-wide in-person and online unconscious bias and antioppression education programs; and a system-wide Disability and Accessibility Workgroup. In partnership with JHM human resources, she helped launched the Levi Watkins, Jr. Mentorship Program, which is designed as part of a talent management strategy focused on identifying and developing high-potential leaders from underrepresented groups. During the COVID-19 pandemic, she facilitated mobile community testing and education for the marginalized in Baltimore City and equitable vaccine distribution to nonclinical, minoritized frontline staff across JHM. Dr. Golden is a leader in the national discussion advancing health equity, including supporting Maryland legislators in drafting and testifying in support of state-level health equity policy. She is an elected member of the National Academy of Medicine, Association of American Physicians, and American Society of Clinical Investigation. She is a member of the Maryland Prescription Drug Affordability Stakeholder Council and was a member of the Data Subcommittee of the Maryland Commission on Health Equity (2022–2024) and cochair of the Health Equity Advisory Committee for the Maryland Hospital Association (2020–2024). In May 2024, Dr. Golden became a member of the North America Medical Advisory Board for Abbott Diabetes Care. She received her M.D. from the University of Virginia and completed her residency in internal medicine and fellowship

in endocrinology, diabetes, and metabolism at Johns Hopkins Hospital. She received her M.H.S. in clinical epidemiology from the Johns Hopkins Bloomberg School of Public Health. Dr. Golden served as a member on the National Academies Committee on Living Well with Chronic Disease.

Holly A. Ingraham, Ph.D., is a professor of cellular and molecular pharmacology and the Herzstein Endowed Professor of Molecular Physiology at the University of California, San Francisco (UCSF) School of Medicine. She also directs the UCSF National Institute of General Medical Sciences–funded Institutional Research and Academic Career Development Award Program to create opportunities for postdoctoral scholars and build diversity in the nation’s biomedical workforce and faculty. Dr. Ingraham’s research focuses on sex differences and hormone-responsive nodes in the brain and peripheral tissues that maintain metabolic, skeletal, and gut physiology in females to address the significant gaps in women’s health. Through question-driven basic science, Dr. Ingraham aims to elucidate the molecular underpinnings of adaptive responses in female physiology across the life-span to understand better the effects of how hormonal fluctuations during the reproductive and postreproductive periods impact females. She has made fundamental contributions to the field of hormone signaling and sex-dependent physiological regulatory mechanisms. Her most recent high-impact studies have been highlighted in the New York Times Science Section (10/26/21) and the NIH Director’s Blog (8/1/24). Dr. Ingraham has chaired and served on scores of National Institutes of Health and other scientific review panels. She is also on several scientific advisory boards and a founder of a new biotech venture to improve women’s health. In addition to numerous scientific awards, she is an elected fellow of the American Association for the Advancement of Science and a member of the National Academy of Sciences and the American Academy of Arts and Science. She earned her Ph.D. from the University of California, San Diego.

Robert M. Kaplan, Ph.D., M.A., is a senior scholar at the Stanford School of Medicine Clinical Excellence Research Center and directs the Stanford-Athena Institute Fund for Behavioral Immunology in Women’s Wellness. He is also a Distinguished Research Professor of Health Policy and Management at the University of California, Los Angeles (UCLA). He served as chief science officer at the Agency for Healthcare Research and Quality (AHRQ) and as associate director of the National Institutes of Health, where he led the behavioral and social sciences programs. He led the UCLA/RAND AHRQ health services training program and the UCLA/RAND Prevention Research Center at the Centers for Disease Control and Prevention. He was chair of the Department of Health Services (2004–2009). From 1997 to 2004, he was professor and chair of the Department of Family and Preventive Medicine at the University of California, San Diego. He is

a past president of five national or international professional organizations and has served as editor in chief for Health Psychology and Annals of Behavioral Medicine. His 21 books and over 600 articles or chapters have been cited more than 76,000 times (h-index >120), and Google Scholar includes him in the list of the most cited authors in science. In 2019, Dr. Kaplan took on a new role as an opinion editorialist, contributing pieces on about a monthly basis. His work has appeared in The Wall Street Journal, USA Today, Los Angeles Times, The Boston Globe, The Mercury News, San Francisco Chronicle, STAT News, RealClear Politics, MedPage, Health Affairs, The Hill, and a variety of other newspapers. Dr. Kaplan was elected to the National Academy of Medicine in 2005. He received his A.B. in psychology from San Diego State University and M.A. and Ph.D. from the University of California, Riverside. He has served on numerous National Academies activities, most recently as a member of the Roundtable on Population Health Improvement.

Nancy E. Lane, M.D., is a distinguished professor of medicine and rheumatology at the University of California Davis School of Medicine and an adjunct professor of immunology and rheumatology at Stanford School of Medicine. Dr. Lane is an internationally recognized expert in research related to musculoskeletal diseases of aging, including osteoarthritis and osteoporosis. She has performed foundational studies to reverse osteoporosis in individuals on chronic glucocorticoids and investigated mechanisms that foster peak bone mass and, on the other end of the life-span, how the skeleton weakens with age. Dr. Lane has also studied osteoarthritis (OA). When, early in her career, she determined that exercise (jogging) did not accelerate the degeneration of knee joints in older runners without known OA, she continued to follow them, finding that exercise of any form increased both the quality of life and life-span. As a translational scientist, Dr. Lane has investigated genetic association with OA of the hip and knee. Dr. Lane has also dedicated her professional career to training the next generation of researchers in musculoskeletal diseases and championed an effort for over 18 years, through the U.S. Bone and Joint Decade/Initiative and National Institutes of Health, to train young investigators to obtain research grants. This has resulted in over 300 new investigators receiving NIH grants. Dr. Lane has also been instrumental in training junior faculty to perform research in women’s health through training grants awarded to the University of California, Davis. In the past, she has consulted with a pharmaceutical company on osteoporosis. Dr. Lane’s accomplishments have been recognized with election to the National Academy of Medicine, National Academy of Inventors, and Association of American Physicians. Dr. Lane received her M.D. from University of California, San Francisco School of Medicine and B.S. from University of California, Davis.

Jane E. Salmon, M.D., is the Collette Kean Research Professor and Director of the Lupus and Antiphospholipid Center of Excellence at Hospital for Special Surgery. She is professor of medicine and obstetrics and gynecology and associate dean of faculty affairs at Weill Cornell College of Medicine. Dr. Salmon’s research has focused on elucidating mechanisms of tissue injury in lupus and other autoimmune diseases. Her basic, translational, and clinical studies have led to a paradigm shift in the understanding of mechanisms of pregnancy loss, cardiovascular disease, and end-organ damage in patients with lupus. Groundbreaking laboratory discoveries about causes of pregnancy loss and preeclampsia, and subsequent observational studies in women with lupus and antiphospholipid syndrome, have allowed her to identify new targets to reduce damage and improve outcomes in patients with autoimmune illness. She is leading the first trial of a biologic therapy to prevent complications in high-risk pregnancies. In recognition of her contributions, she was awarded the Carol Nachman international prize in rheumatology, Virginia Kneeland Frantz ’22 Distinguished Women in Medicine Award from the Columbia P&S Alumni Association, and Evelyn V. Hess Award from the Lupus Foundation of America. She has been recognized as a Master of the American College of Rheumatology and elected to the American Association of Physicians and National Academy of Medicine. She also serves on the board of scientific counselors for the National Institute of Arthritis and Musculoskeletal and Skin Diseases and board of directors of the New York Community Trust. She has previously served on scientific advisory boards for a pharmaceutical company manufacturing autoimmunity medications. Dr. Salmon graduated magna cum laude from New York University and earned her M.D. in 1978 from the College of Physicians and Surgeons of Columbia University, where she was the first woman enrolled in its Medical Scientist Training Program. She completed training in internal medicine at the New York Hospital and in rheumatology at Hospital for Special Surgery.

Crystal Edler Schiller, Ph.D., is a licensed clinical psychologist and tenured associate professor of psychiatry at the University of North Carolina (UNC) at Chapel Hill. She serves as associate director of the UNC Center for Women’s Mood Disorders and director of the UNC School of Medicine Clinical Psychology Internship Program. She conducts a National Institutes of Health–funded research program that focuses on sex steroid regulation of neural circuits and mood in women across the reproductive life-span. Her research also aims to identify novel ways to expand access to evidence-based psychotherapy. Dr. Schiller completed predoctoral training in clinical psychology at the University of Iowa, T32-funded postdoctoral training in reproductive hormone–related mood disorders and affective neuroscience at UNC Chapel Hill, and a K23 career development award focused on the effects of estrogen on the neural reward system in perimenopause.

Angeles Alvarez Secord, M.D., M.H.Sc., is a professor in the Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, in the Duke University Health System. She is the director of Gynecologic Oncology Clinical Trials, associate director of Clinical Research, Gynecologic Oncology, and NRG Oncology principal investigator (PI) at the Duke Cancer Institute. She is the site PI for numerous clinical trials related to female-specific cancers. Dr. Secord served as a board member for the GOG Foundation, Foundation for Women’s Cancer, Society of Gynecologic Oncology, and American Association Obstetricians and Gynecologists Foundation. She participated in scientific advisory meetings for GSK on endometrial cancer and AbbVie relating to ovarian cancer in 2024; she served on other advisory boards and clinical trial steering committees for pharmaceutical companies prior to serving on this National Academies committee. She also participated in educational meetings related to gynecologic malignancies for which she reviewed honoraria. She is committed to mentoring the next generation of clinical trialists with expertise in translational research and serves as the NRG Oncology New Investigator Committee vice chair and GOG Foundation Education and Mentoring chair. Her research interests include novel therapeutics and biomarker development to direct treatment for patients with gynecologic cancer. She has received National Institutes of Health and Department of Defense funding and numerous institutional, regional, and national awards for her research. Dr. Secord is a fellow of the American College of Obstetricians and Gynecologists and an active member of American Society of Clinical Oncology, American Gynecological & Obstetrical Society, and International Gynecologic Cancer Society. She received her undergraduate degree with honors from Carroll College and graduated Alpha Omega Alpha with honors from the University of Washington School of Medicine. Dr. Secord completed her residency in obstetrics and gynecology and fellowship in gynecologic oncology at the Duke University Medical Center.

Methodius G. Tuuli, M.D., M.B.A., M.P.H., is the Chace-Joukowsky Professor and chair of the Department of Obstetrics and Gynecology at the Warren Alpert Medical School of Brown University and Chief of Obstetrics and Gynecology at Women & Infants Hospital. His top priority is to improve the quality of maternal care and eliminate disparities in perinatal outcomes. A board-certified maternal-fetal medicine physician, he focuses on predicting and preventing adverse obstetric outcomes, including preventing surgical site infection after cesarean delivery, managing labor, and optimizing management of medical complications in pregnancy. He leads three R01s for ongoing multicenter trials on treating postpartum hemorrhage, managing anemia in pregnancy, and optimizing glycemic control in overweight and obese women with gestational diabetes. He also leads a Department of Health and Human Services grant to develop a participatory model for integrating

community-based maternal support services into perinatal care to address care coordination and social determinants of health and test the impact on perinatal health equity. Dr. Tuuli is an elected member of the National Academy of Medicine. He earned his M.D. from the University of Ghana Medical School in 2001 and M.P.H. from the University of California, Berkeley with concentration in maternal and child health in 2003. He completed residency training in obstetrics and gynecology at Emory University in 2008 and fellowship training in maternal-fetal medicine at Washington University in 2011. Dr. Tuuli completed the Business of Medicine Physician M.B.A. program at the Kelley School of Business at Indiana University in 2020.

Bianca D. M. Wilson, Ph.D., is an associate professor in the Department of Social Welfare and affiliate faculty member of the California Center for Population Research at the University of California, Los Angeles (UCLA). She was a Senior Scholar of Public Policy at the Williams Institute on Sexual Orientation and Gender Identity Law and Public Policy at UCLA School of Law. Her research explores the relationships between culture, oppression, and health. Dr. Wilson examines lesbian, gay, bisexual, transgender, and queer (LGBTQ) economic instabilities and involvement with systems of care and criminalization, with a focus on how racialization, sexual orientation, gender identity, and gender expression play a role in creating disproportionality and disparities. Notably, she was the lead investigator on the first study to establish population estimates of how many LGBTQ youth are in foster care and has led similar work in juvenile criminalization. Similarly, she has led the largest qualitative study of the life and needs of LGBTQ people experiencing economic insecurity. Acknowledging the impact of this work, she was awarded the Distinguished Contribution to Public Policy Award by the American Psychological Association Division 44 (Society for the Psychology of Sexual Orientation and Gender Diversity). Underlying her substantive work on LGBTQ health, system involvement, and economic security is her attention to sexual orientation, gender identity, and gender expression data collection and data policy; she has conducted this measurement research among youth and adults and continues to work with local, state, and federal government efforts on increasing and improving LGBTQ-inclusive data collection. She served on the National Academy of Sciences, Engineering, and Medicine Consensus Panel on the Measurement of Sex, Gender, and Sexual Orientation. Dr. Wilson earned her Ph.D. in psychology from the Community and Prevention Research program at the University of Illinois at Chicago with a minor in statistics, methods, and measurement and received postdoctoral training at the University of California, San Francisco (UCSF) Institute for Health Policy Studies and the UCSF Lesbian Health and Research Center through an AHRQ postdoctoral fellowship. She served on the National Academies Panel on Measuring Sex, Gender Identity, and Sexual Orientation for the National Institutes of Health.

National Academy of Medicine Fellows

2023–2025 Gant/American Board of Obstetrics and Gynecology Fellow

Michelle P. Debbink, M.D., Ph.D., is a maternal-fetal medicine specialist and assistant professor at the University of Utah in the Department of Obstetrics and Gynecology. She also serves as the departmental vice chair for Equity, Diversity, and Inclusion for the Obstetrics and Gynecology Department. Her clinical interests include complex maternal and fetal care, with a particular emphasis on high-quality, responsive care for structurally and historically marginalized people with high-risk pregnancies. She has focused her clinical, professional, and investigational efforts on the structural and community factors that contribute to racial and geographic health equity in pregnancy outcomes. As a Reproductive Scientist Development Program scholar, she conducts community-engaged mixed-methods research with Native Hawaiian and Pacific Islander and Native American/Indigenous mothers to understand community risk and resilience related to maternal morbidity and perinatal health. These collaborations have resulted in multiple funded awards to develop, implement, and test culturally responsive interventions for perinatal mental health, substance use disorders, and respectful care. She also has expertise in geographic information science as applied to population health and social epidemiology analyses that inform and bolster qualitative and community-led research. She serves as a committee member for the Utah Perinatal Mortality Review Committee. Dr. Debbink earned her M.D. and Ph.D. in health services organization and policy at the University of Michigan. She completed her obstetrics and gynecology residency at the University of Michigan and maternal-fetal medicine fellowship at the University of Utah.

2021–2023 American Board of Emergency Medicine Fellow

Tracy Madsen, M.D., Ph.D., FAHA, FACEP, is an associate professor of emergency medicine and epidemiology at Brown University, the vice chair of research in the Department of Emergency Medicine, and interim director of the Division of Sex and Gender in Emergency Medicine. She has expertise in sex and gender-based medicine, women’s health, acute cerebrovascular disease, stroke epidemiology and prevention, and disparities in the health care system. Dr. Madsen’s research is funded by the National Heart, Lung, and Blood Institute, the American Heart Association, and the Agency for Healthcare Research and Quality. She has over 110 peer-reviewed publications and speaks nationally and internationally on topics including stroke in women, health inequities in stroke, and disparities in the academic medicine workforce. She is regarded as an expert in the fields of cerebrovascular and cardiometabolic disease in women. Dr. Madsen is an active investigator in the Women’s Health Initiative Study, where she leads the stroke/venous

thromboembolism working group and serves as a consultant for both the Fred Hutchinson Cancer Center and Western Regional Coordinating Center at Stanford University. Dr. Madsen received her M.D. from Boston University School of Medicine and completed a residency, with her last year as chief resident, at Brown University before completing a research fellowship in the Division of Sex and Gender Medicine at Brown University. She then completed an M.S. in clinical and translational research and a Ph.D. in epidemiology, both at the Brown University School of Public Health. She is also a 2021 National Academy of Medicine Fellow in Emergency Medicine.

STAFF

Amy Geller, M.P.H., is a senior program officer in the Health and Medicine Division (HMD) on the Board on Population Health and Public Health Practice. During her 20 years at the National Academies, she has staffed committees spanning many topics, including advancing health equity, prevention of sexually transmitted infections, reducing alcohol-impaired driving fatalities, workforce resilience, vaccine safety, reducing tobacco use, drug safety, and treating post-traumatic stress disorder. She was and is the study director, respectively, for the recently released HMD report Federal Policy to Advance Racial, Ethnic, and Tribal Health and the HMD Committee on the Assessment of NIH Research on Women’s Health. She also directs the DC Public Health Case Challenge, a joint activity of HMD and NAM that aims to promote interdisciplinary, problem-based learning for college students at universities in the DC area.

Aimee Mead, M.P.H., is a program officer in the Health and Medicine Division and on the Board on Population Health and Public Health Practice. She has supported National Academies consensus studies on a range of public health challenges, including eliminating hepatitis B and C in the United States, reducing alcohol-impaired driving, reviewing the health consequences of e-cigarettes, preventing sexually transmitted infections, evaluating the health effects and patterns of use of premium cigars, and reviewing federal policies that contribute to racial and ethnic health inequities. Earlier, she worked at the National Heart, Lung, and Blood Institute. She holds an M.P.H. from the Yale School of Public Health (epidemiology) and B.S. (biology) from Cornell University.

L. Brielle Dojer, M.P.H., is a research associate in the Health and Medicine Division and on the Board on Population Health and Public Health Practice. She holds an M.P.H. from the Icahn School of Medicine at Mount Sinai and a B.A. in biology from Boston University. Earlier, she worked on health equity issues as an intern with the Access Challenge, a 501(c)(3) nonprofit,

and as a volunteer with the student-founded organization ContraCOVID NYC. She also worked in research laboratories at NYU Langone and Mount Sinai Hospital before pursuing a career in public health.

Maggie Anderson, M.P.H., is an HMD research assistant and on the Board on Population Health and Public Health Practice. Earlier, she worked at Program Savvy Consulting as an independent contractor and as an intern with the Food Policy Council of Buffalo and Erie County. She received a B.A. in biology with a minor in environmental studies from Mount Holyoke College and her M.P.H. from George Mason University.

Rachel Riley Sorrell was a senior program assistant in HMD on the Board on Population Health and Public Health Practice. She received her B.S. in public health and politics and international affairs from Furman University. Earlier, she worked at different health advocacy nonprofits in South Carolina and Washington, DC as a health policy/law intern.

Rose Marie Martinez, Sc.D., has been the director of the Health and Medicine Division (formerly the Institute of Medicine) Board on Population Health and Public Health Practice since 1999. Dr. Martinez was a senior health researcher at Mathematica Policy Research (1995–1999), where she conducted research on the impact of health system change on the public health infrastructure, access to care for vulnerable populations, managed care, and the health care workforce. She is a former assistant director for Health Financing and Policy with the Government Accountability Office and served for 6 years directing research studies for the Regional Health Ministry of Madrid, Spain.

Y. Crysti Park is a program coordinator in the Health and Medicine Division on the Board on Population Health and Public Health Practice. Earlier, she was in marketing and sales management for over 15 years, working on creating catalogs, merchandising, and production in the garment industry. She attended the Fashion Institute of Technology and Cornell University.

This page intentionally left blank.